Protective mechanisms of exosomes derived from human umbilical cord mesenchymal stem cells in bronchopulmonary dysplasia
- PMID: 40698659
Protective mechanisms of exosomes derived from human umbilical cord mesenchymal stem cells in bronchopulmonary dysplasia
Abstract
Bronchopulmonary dysplasia (BPD) is characterized by reduced alveolar formation and disordered matrix remodeling. Currently, there are no effective therapeutic approaches for it. This study aims to explore the protective effect of exosomes derived from human umbilical cord mesenchymal stem cells on BPD by regulating the immune response and inflammatory pathways of macrophages. PKH26-labeled human umbilical cord mesenchymal stem cell line exosomes (hUCMSC-Exos) were co-cultured with RAW264.7 cells, which were assigned to the following groups: normoxia, normoxia + NLRP3 activator (Nigericin), normoxia + hUCMSC-Exos + Nigericin, hyperoxia, hyperoxia + hUCMSC-Exos, and hyperoxia + hUCMSC-Exos + Nigericin. Cell viability and cytokine expression in cell supernatant were measured for each group. PKH26 exosome staining confirmed successful uptake of hUCMSC-Exos by RAW264.7 cells. hUCMSC-Exos demonstrated protective effects against reductions in cell viability induced by both Nigericin and hyperoxia. Cells in the Hyperoxia group showed significantly increased expression of inflammatory cytokines IL-33, IL-6, IL-1beta, TNF-alpha, and IL-18 compared to those in the Normoxia group, along with elevated mRNA and protein levels of NLRP3, ASC, caspase-1, IL-18, IL-1beta, and ATF4. The Hyperoxia + hUCMSC-Exos group exhibited reduced expression of IL-33, IL-6, IL-1beta, TNF-alpha, IL-18 and IL-33, IL-6, IL-1beta, TNF-alpha, and IL-18 compared to the Hyperoxia group. In contrast, the Hyperoxia + hUCMSC-Exos + Nigericin group showed elevated levels of IL-33, IL-6, IL-1beta, TNF-alpha, and IL-18, as well as increased expression of NLRP3, ASC, caspase-1, IL-18, IL-1beta, and ATF4 compared to the Hyperoxia + hUCMSC-Exos group. hUCMSC-Exos mitigate hyperoxia-induced damage to lung macrophages by reducing endoplasmic reticulum stress, inhibiting NLRP3 inflammasome expression, and regulating inflammatory cytokine release, that may be potentially useful in BPD. Key words Bronchopulmonary dysplasia " Exosomes " Human umbilical cord mesenchymal stem cells " Macrophages " NLRP3.
Similar articles
-
Human umbilical cord mesenchymal stem cell exosomes promote elastin production and acute skin wound healing via TGFβ1-Smad pathway.Mol Cell Biochem. 2025 Jul;480(7):4499-4511. doi: 10.1007/s11010-025-05264-5. Epub 2025 Apr 9. Mol Cell Biochem. 2025. PMID: 40202710 Free PMC article.
-
hucMSC-derived exosomes targeting macrophage polarization attenuate systemic inflammation in T1DM via INS/SOD1 delivery.Stem Cell Res Ther. 2025 Jul 18;16(1):384. doi: 10.1186/s13287-025-04521-0. Stem Cell Res Ther. 2025. PMID: 40682139 Free PMC article.
-
Human umbilical cord mesenchymal stem cell-derived exosomes inhibit inflammation and fibrotic scar formation after intracerebral hemorrhage.Mol Cell Biochem. 2025 Aug;480(8):4829-4847. doi: 10.1007/s11010-025-05259-2. Epub 2025 Apr 25. Mol Cell Biochem. 2025. PMID: 40279088 Free PMC article.
-
Research landscape and trends of human umbilical cord mesenchymal stem cell-derived exosomes.Stem Cell Res Ther. 2025 May 28;16(1):259. doi: 10.1186/s13287-025-04379-2. Stem Cell Res Ther. 2025. PMID: 40437553 Free PMC article. Review.
-
Mesenchymal stem cell-derived exosomes for the treatment of knee osteoarthritis: a systematic review and meta-analysis based on rat model.Front Pharmacol. 2025 Jun 2;16:1588841. doi: 10.3389/fphar.2025.1588841. eCollection 2025. Front Pharmacol. 2025. PMID: 40529485 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous